Manuel Burdese

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Impact of contrast-induced acute kidney injury definition on clinical outcomes

Carlo Budano, Mario Levis, Maurizio D’Amico et al. · American Heart Journal · 2011 · 73 citations

Renal Function, Clinical Injury, Organ Injury +7

Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation

A. Ranghino, Davide Diena, Francesca Simonato et al. · SpringerPlus · 2016 · 28 citations · Full text

Pf Bacterial Contamination, Pathogenic Microbiology, Perfusion Fluid +16

Low-dose continuous iron therapy leads to a positive iron balance and decreased serum transferrin levels in chronic haemodialysis patients

Carlotta Canavese, D. Bergamo, Giovannino Ciccone et al. · Nephrology Dialysis Transplantation · 2004 · 27 citations · Full text